Literature DB >> 5171067

Absorption and metabolism of levodopa.

W B Abrams, C B Coutinho, A S Leon, H E Spiegel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5171067

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  13 in total

1.  [Tyrosine hydroxylase activity is increased by homovanillic acid (author's transl)].

Authors:  U Kollner; E Gründig
Journal:  Experientia       Date:  1977-04-15

2.  Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease.

Authors:  M Contin; R Riva; P Martinelli; F Albani; A Baruzzi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Chronic levodopa therapy enhances dopa absorption: contribution to wearing-off.

Authors:  M Murata; H Mizusawa; H Yamanouchi; I Kanazawa
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.

Authors:  D R Robertson; N D Wood; H Everest; K Monks; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

5.  Peripheral pharmacokinetic parameters of levodopa/carbidopa and the on-off phenomenon in parkinsonian patients.

Authors:  I Rainero; M Gilli; T De Gennaro; I Chiadò; M Delsedime; A Riccio; B Bergamasco
Journal:  Ital J Neurol Sci       Date:  1988-06

Review 6.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

8.  Systemic activity of orally administered L-dopa in the elderly Parkinson patient.

Authors:  M A Evans; E J Triggs; G A Broe; N Saines
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

9.  Simultaneous voltammetric sensing of levodopa, piroxicam, ofloxacin and methocarbamol using a carbon paste electrode modified with graphite oxide and β-cyclodextrin.

Authors:  Anderson Martin Santos; Ademar Wong; Fernando Campanhã Vicentini; Orlando Fatibello-Filho
Journal:  Mikrochim Acta       Date:  2019-02-15       Impact factor: 5.833

10.  Treatment of idiopathic parkinsonism with L-dopa in the absence and presence of decarboxylase inhibitors: effects on plasma levels of L-dopa, dopa decarboxylase, catecholamines and 3-O-methyl-dopa.

Authors:  F Boomsma; J D Meerwaldt; A J Man in't Veld; A Hovestadt; M A Schalekamp
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.